欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2271/001
药品名称
Sorafenib Mylan
活性成分
SORAFENIB TOSILATE 200.0 mg
剂型
Film-coated tablet
上市许可持有人
Mylan AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Norway (NO)
Germany (DE)
Sorel 200 mg Filmtabletten
Denmark (DK)
Iceland (IS)
Sorafenib Mylan 200 mg Filmuhúðuð tafla
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Finland (FI)
Czechia (CZ)
Sorel
Romania (RO)
Sorel 200 mg comprimate filmate
Croatia (HR)
Sorafenib Mylan 200 mg filmom obložene tablete
许可日期
2020/06/05
最近更新日期
2024/11/08
药物ATC编码
L01EX02 sorafenib
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
Sorafenib Mylan 200 mg film_coated tablet ENG PAR
Date of last change:2024/09/06
PubAR Summary
|
Sorafenib Mylan 200 mg film_coated tablet ENG sPAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase